top of page
PreferUS in Motion
As we continue to build our presence throughout the China healthcare market, we want to bring you along. Our new limited series, "Stories Of A Startup," provided an in-depth look at PreferUS on how we began and where we are ultimately preparing to go. Additionally, major announcements and future episodes from our series will be made available through this section. Stay tuned for much more!
Stories Of A Startup | A Limited Series
"Bridging The Gap" | S1.E3
In our third episode, we focus on establishing and cultivating partnerships with several China hospital systems, with the goal of expanding the PreferUS name within the emerging China healthcare market. Additionally, we highlight one of our more rewarding offerings, the U.S. Immersion Program as well as our newest strategic partner based in Jakarta, Sinar Mas Group. We close with details on our fourth and final episode that will serve as a major announcement for where the future of PreferUS is heading as we join forces with our partner, Kerlan-Jobe Orthopedic Clinic.
"Patience and Persistence" | S1.E2
In our second episode, we will show you how an emerging market demand in China led to diversifying our model and welcoming Oklahoma Heart Hospital and Cedars-Sinai Medical Center as our newest institutional investor partners. Additionally, we introduce you to the PreferUS team from both our Shanghai and Kansas City offices. Each member will share their role, unique work experience, and personal outlook on the future of PreferUS. Lastly, we share our thoughts on the importance of utilizing two distinct characteristics that we've found to be essential to our longevity in an evolving market.
"If We Knew Then, What We Know Now..." | S1.E1
In this introductory episode on the history of PreferUS Healthcare, the audience will be given a firsthand look at the early stages of PreferUS as told by Director of Marketing and Training, David Franz. The story of PreferUS is one that has seen its share of obstacles, achievements, and possesses a will to succeed in the ever-evolving healthcare market of China.
bottom of page